Splash Clinical

Splash Clinical and C2N to improve Alzheimers trial recruitment process Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's disease. The post Splash Clinical and C2N to improve Alzheimer’s trial recruitment process appeared first on Medical Device N... https://lnkd.in/daQje8aC #BioTech #science

Splash Clinical and C2N Diagnostics Partner to Transform Global Clinical Trial Recruitment for Alzheimer's Disease The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient experience. Under the partnership, Splash Clinical will provide a new clinical trial recruitment program that combines Splash's proprietary recruitment infrastructure with C2N's PrecivityAD2™ blood tests. The tests help healthcare providers in the detection of amyloid plaques in the brain, a pathological hallmark of Alzheimer's disease. "C2N Diagnostics prides itself on collaborating with the leading entities and researchers in the world to better understand the causes of Alzheimer’s disease as well as ways to better diagnose and treat it. This is why we’re excited to partner with Splash and its patient-centric platform focus,” said Joel Braunstein, MD, C2N CEO. “C2N assays have been used in over 150 Alzheimer’s disease and other research studies, and we’re confident even more clinical trials will benefit as a result of this new initiative that seeks to ease recruitment and accuracy for all involved.” https://lnkd.in/e7xZZVrD #clinicaltrials #SplashClinical #clinicaltrialrecruitment #bloodtests #Alzheimersresearch #amyloid #precisionmedicine  

Splash Clinical and C2N Diagnostics Partner to Transform Global Clinical Trial Recruitment for Alzheimer's Disease. The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient experience. Under the partnership, Splash Clinical will provide a new clinical trial recruitment program that combines Splash's proprietary recruitment infrastructure with C2N's PrecivityAD2™ blood tests. The tests help healthcare providers in the detection of amyloid plaques in the brain, a pathological hallmark of Alzheimer's disease. "Our partnership with C2N Diagnostics is a step forward in our mission to transform clinical trial enrollment," said Matt Teuteberg, CEO of Splash Clinical. "We believe by using C2N's PrecivityAD2 blood tests in our platform, we can reduce screen failure rates, which often exceed 70% (Goldman et al., 2020) in Alzheimer's trials, while saving valuable time and resources for our partners. In the end, this means getting potentially life-changing treatments to patients faster." To stay up to date on the latest from Splash, be sure to subscribe to our newsletter: https://lnkd.in/g-iVUs9S Press Release: https://lnkd.in/e7xZZVrD Source Above: (Goldman et al., 2020) https://lnkd.in/giEXdSzR #ClinicalTrials #InnovativePartnerships #AlzheimersResearch #Biomarkers #InnovationInHealthcare #PatientEnrollment #CNSResearch #HealthcarePartnerships #LifeSciences #DrugDevelopment #ClinicalTrialRecruitment #PatientCentricity #ClinicalResearch

DYK? Over 80% of clinical trials face delays and increased costs due to patient retention challenges, with an even greater impact on rare disease research, where every participant is vital. Reaching recruitment goals is just the beginning—keeping patients engaged is essential to the success of a study. Our patient retention program ensures rare disease trial participants stay informed, supported, and connected without feeling overwhelmed. To stay up to date on the latest from Splash, be sure to subscribe to our newsletter at: https://lnkd.in/g-iVUs9S #ClinicalTrials #PatientCentricity #ResearchInsights #PatientRetention #PatientEngagement #RareDisease

Accelerating trial enrollment just got easier! Our new Pre-Enrollment Registry is a dynamic platform that engages, educates, and nurtures patients before your trial even begins. With personalized communication and actionable insights, we help build a trial-ready group of participants, reducing the risk of delays and saving time, money, and resources. Ready to transform your trial enrollment process? Learn more: https://lnkd.in/gtV89Txm #ClinicalTrials #PatientEngagement #TrialEnrollment

We have an exciting year ahead at Splash Clinical! We’ll introduce comprehensive solutions that cover the entire clinical trial enrollment process. From pre-Phase 1 preparation to supporting sites and patients through the end of Phase 3, Splash is ready to help you achieve your enrollment goals every step of the way. To stay up to date on the latest from Splash, be sure to subscribe to our newsletter. Subscribe here: https://lnkd.in/g-iVUs9S #ClinicalTrials #PatientCentricity #ResearchInsights #PatientEnrollment

Did you know? Our latest report on clinical trial recruitment uncovered an inspiring insight: 𝟳𝟬% 𝗼𝗳 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀 𝗷𝗼𝗶𝗻 𝘁𝗿𝗶𝗮𝗹𝘀 𝘁𝗼 𝗮𝗱𝘃𝗮𝗻𝗰𝗲 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝗱𝗿𝘂𝗴 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁. This overwhelming altruism highlights the importance of emphasizing the social impact of clinical trials in recruitment strategies. By focusing on the benefits to society and the potential to save lives, we can connect with participants driven by a purpose greater than themselves. At Splash Clinical, we're committed to harnessing these insights to craft messaging that resonates and motivates. Together, we can drive innovation and improve healthcare for all. Curious about our findings? Request your FREE copy today: https://lnkd.in/gr9FbeSZ #ClinicalTrials #HealthcareInnovation #patientcentric #PatientEngagement #MedicalResearch

As we move into 2025, clinical trial recruitment continues to evolve, driven by emerging trends and patient-centric imperatives. At Splash Clinical, we’ve identified key areas shaping the field, offering both opportunities and challenges: 𝟭. 𝗣𝗿𝗲-𝗘𝗻𝗿𝗼𝗹𝗹𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗥𝗲𝘁𝗲𝗻𝘁𝗶𝗼𝗻: The importance of focusing on pre-enrollment processes and retention strategies cannot be overstated. Streamlining these areas accelerates recruitment and ensures more consistent participation throughout the study lifecycle. 𝟮. 𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝘀: Patient experience is at the core of successful trials. A positive experience benefi ts all stakeholders—patients, sites, and sponsors. This means addressing accessibility, convenience, and communication at every stage. 𝟯. 𝗗𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗶𝗻 𝗥𝗲𝗰𝗿𝘂𝗶𝘁𝗺𝗲𝗻𝘁: Supporting diversity remains a priority, aligned with the FDA’s evolving guidelines. Emphasizing inclusivity ensures more representative and equitable trials. By adopting a more precise and strategic approach, we can drive impactful results that benefit trials and the broader healthcare ecosystem. What trends do you see shaping clinical trials in 2025? Let us know in the comments below. Sign up for our newsletter to stay up to date on our latest developments: https://lnkd.in/g-iVUs9S #ClinicalTrials #PatientExperience #Diversity #RecruitmentInnovation

Patients have spoken: flexibility in clinical trials is crucial for their willingness to participate. Our latest survey explores the need for designing trials that accommodate patient preferences, especially in remote rural locations. Our recent report, “Patient-Centric Approaches to Clinical Trials,” explores Americans' perspectives on clinical trial recruitment. https://lnkd.in/gr9FbeSZ Sign up for our newsletter to stay up to date on the latest developments: https://lnkd.in/g-iVUs9S #ClinicalTrials #HealthcareInnovation #patientcentric #PatientEngagement #MedicalResearch

Thank you to the Sponsors, CROs, and Sites who attended the Splash Clinical Summit. It was a great day filled with insights from clinical trial patients and collaborative conversations about diversity and engagement. And special thanks to our keynote speaker, Dr. Josephine Grima from The Marfan Foundation, who showed us the power of advocacy groups and what meaningful partnerships can accomplish! The participation, openness, and experience filled us with excitement and eagerness to turn the learnings into innovations that will continue to redefine patient recruitment! #SplashClinicalSummitRaleigh #MarfanFoundation #PatientRecruitment #SplashSummit2024